Aureon Laboratories

company

About

Aureon Laboratories focused on developing the advancement of predictive and personalized cancer treatment options.

Details

Last Funding Type
Series D
Last Funding Money Raised
$7M
Industries
Biotechnology,Health Diagnostics,Life Science
Founded date
Jan 1, 2001
Operating Status
Active

Aureon Laboratories is a life sciences company dedicated to enabling the advancement of predictive and personalized cancer treatment. Aureon provides objective, actionable information allowing patients and physicians to make more-informed treatment decisions through its prostate diagnostic tools.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$7M
Aureon Laboratories has raised a total of $7M in funding over 2 rounds. Their latest funding was raised on Apr 14, 2010 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 14, 2010 Series D $7M 1 Detail
Mar 5, 2010 Series C 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Aureon Laboratories is funded by 1 investors. Pfizer are the most recent investors.
Investor Name Lead Investor Funding Round
Pfizer Series D